Cyclosporine immunosuppression in cadaver kidney recipients with a remote positive crossmatch to the current donor
Belitsky, P.
Transplantation Proceedings 17(4): 1937-1939
1985
ISSN/ISBN: 0041-1345 PMID: 3895633 Document Number: 249615
Document emailed within 1 workday
Related Documents
Hourmant, M.; Bignon, J.D.; Cesbron, A.; Soulillou, J.P. 1990: Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one-center study Clinical Transplants 1990: 301-309Reissi, D.; Bardideh, A.; Samadzadeh, B.; Razi, A. 1995: Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation Transplantation Proceedings 27(5): 2685-2686
Salomon, D.R. 1991: An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients Transplantation Proceedings 23(4): 2115-2118
Bradley, J.W.; Cho, S.I.; Cosimi, A.B.; Monaco, A.P. 1987: Cyclosporine immunosuppression and perfusion preservation of cadaver kidneys Transplantation Proceedings 19(1 Part 3): 2104-2105
Gaber, A.O.; Thistlethwaite, J.R.; Haag, B.W.; Stuart, J.; Mayes, J.; Fellner, S.; Stuart, F.P. 1987: Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors Transplantation Proceedings 19(1 Part 3): 1915-1916
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Gruber, S.A.; Skjei, K.L.; Sothern, R.B.; Robison, L.; Tzardis, P.; Moss, A.; Gillingham, K.; Canafax, D.M.; Matas, A.J.; Dunn, D.L. 1991: Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression Transplantation Proceedings 23(1 Pt 2): 1104-1105
Fung, J.J.; Todo, S.; Tzakis, A.; Demetris, A.; Jain, A.; Abu-Elmaged, K.; Alessiani, M.; Starzl, T.E. 1991: Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls Transplantation Proceedings 23(1 Part 1): 14-21
Corry, R.J.; Thompson, J.S.; Freeman, R.M.; Colville, D.S. 1978: Critical comparison of renal transplant survival between recipients of live related donor and cadaver organs Surgery Gynecology and Obstetrics 146(4): 519-523
Thistlethwaite, J.R.; Heffron, T.G.; Stevens, L.; Buckingham, M.; Stuart, J.K.; Stuart, F.P. 1990: The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation Transplantation Proceedings 22(4): 1897-1898
Blaschke, J.; Flink, R.; Thompson, J.S.; Freeman, R.; Corry, R.J. 1977: Feasibility of HLA haplotype matching of cadaver kidney donors and recipients Transplantation Proceedings 9(4): 1799-1802
Cosio, F.G.; Elkhammas, E.A.; Henry, M.L.; Pesavento, T.E.; Sedmak, D.D.; Pelletier, R.P.; Bumgardner, G.L.; Ferguson, R.M. 1998: Function and survival of renal allografts from the same donor transplanted into kidney-only or kidney-pancreas recipients Transplantation 65(1): 93-99
Pappalettera, M.; Pizzi, C.; Cardillo, M.; Piccolo, G.; Aniasi, A.; Lecchi, L.; Poli, F.; Sirchia, G. 1994: Factors influencing cadaver kidney graft survival in two cyclosporine periods Transplantation Proceedings 26(5): 2533-2534
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112
Gjertson, D.W. 1991: Survival trends in long-term first cadaver-donor kidney transplants Clinical Transplants 1991: 225-235
Haberal, M.; Emiroglu, R.; Karakayali, H.; Moray, G.; Arslan, G.; Bilgin, N. 2002: Cadaver kidney transplantation and the nationwide donor-organ coordination system in Turkey Clinical Transplants 2002: 201-206
Vereerstraeten, P.; Andrien, M.; Dupont, E.; De Pauw, L.; Kinnaert, P.; Toussaint, C. 1987: Influence of donor and recipient DRw6 status on outcome of cadaver kidney transplantation Transplantation Proceedings 19(1 Part 1): 708-710
Ettenger, R.B.; Opelz, G.; Walker, J.; Terasaki, P.I.; Malekzadeh, M.H.; Pennisi, A.J.; Uittenbogaart, C.H.; Fine, R.N. 1978: Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients Transplantation Proceedings 10(2): 479-481
Schulak, J.A.; Novick, A.C.; Sharp, W.V.; Ford, E. 1990: Donor pretreatment with lidocaine decreases incidence of early renal dysfunction in cadaver kidney transplantation Transplantation Proceedings 22(2): 353-354
Campise, M.; Tarantino, A.; Berardinelli, L.; Finazzi, S.; Montagnino, G.; Rossini, G.; Scalamogna, M.; Cesana, B.; Ponticelli, C. 2002: Living-donor kidney transplantation in the cyclosporine era Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(1): 49-54